Sun, Xiaofan
Li, Yue
Du, Juan https://orcid.org/0000-0003-4701-3573
Liu, Fangshu
Wu, Caiping
Xiao, Weihao
Yu, Guopan
Chen, Xiaowei
Gale, Robert Peter
Zeng, Hui https://orcid.org/0000-0002-4498-8888
Article History
Received: 7 January 2024
Accepted: 21 January 2025
First Online: 4 February 2025
Competing interests
: The Authors declare the following competing interests: R.P.G. is a consultant to NexImmune Inc. Nanexa Pharma Ascentage Pharm Group and Antengene Biotech LLC, Medical Director of FFF Enterprises Inc.; Partner in AZCA Inc.; Board of Directors of Russian Foundation for Cancer Research Support and Scientific Advisory Board of StemRad Ltd. Other authors declare no competing interests.